Skip to content
PoliticalRepoPoliticalRepo

European Union · Record · TO

CELEX 62025TO0637(01)

Order of the General Court (Ninth Chamber) of 12 October 2026.#Merck Europe BV v European Commission.#Application for annulment – Public health – Medicinal products for human use – Marketing authorisation for MAVENCLAD – cladribine – Request for administrative assistance concerning the scope and extent of the marketing authorisation – Commission’s response – Act not open to challenge – Inadmissibility.#Case T-637/25.

decidedEuropean Union· Court of Justice of the European Union· EN

Introduced

12 October 2026

Last action

12 October 2026 · Decided

Status

decided

Sponsors

—

Subjects

Healthcare

Source updated

12 October 2026

Healthcare

Official sourceDownload fileView documentsShare

Official titles

Authentic titles published by the source. The stored canonical title is not replaced.

1 official language

  • French

    Ordonnance du Tribunal (neuvième chambre) du 12 octobre 2026.#Merck Europe BV contre Commission européenne.#Recours en annulation – Santé publique – Médicaments à usage humain – Autorisation de mise sur le marché du MAVENCLAD - cladribine – Demande d’assistance administrative concernant la portée et l’étendue de l’autorisation de mise sur le marché – Réponse de la Commission – Acte non susceptible de recours – Irrecevabilité.#Affaire T-637/25.

Records

Official record CELEX 62025TO0637(01) from European Union at Court of Justice of the European Union. Dated 12 October 2026. Status: decided.

Timeline

  1. 12 October 2026

    Decided

    Source: work_date_document

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

Ordonnance du Tribunal (neuvième chambre) du 12 octobre 2026.#Merck Europe BV contre Commission européenne.#Recours en annulation – Santé publique – Médicaments à usage humain – Autorisation de mise sur le marché du MAVENCLAD - cladribine – Demande d’assistance administrative concernant la portée et l’étendue de l’autorisation de mise sur le marché – Réponse de la Commission – Acte non susceptible de recours – Irrecevabilité.#Affaire T-637/25.

View fileDownload file

Reading translation

Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Ordonnance du Tribunal (neuvième chambre) du 12 octobre 2026.#Merck Europe BV contre Commission européenne.#Recours en annulation – Santé publique – Médicaments à usage humain – Autorisation de mise sur le marché du MAVENCLAD - cladribine – Demande d’assistance administrative concernant la portée et l’étendue de l’autorisation de mise sur le marché – Réponse de la Commission – Acte non susceptible de recours – Irrecevabilité.#Affaire T-637/25.

    judgment · FR · 12 October 2026

    ViewDownloadOpen at official source

  • Order of the General Court (Ninth Chamber) of 12 October 2026.#Merck Europe BV v European Commission.#Application for annulment – Public health – Medicinal products for human use – Marketing authorisation for MAVENCLAD – cladribine – Request for administrative assistance concerning the scope and extent of the marketing authorisation – Commission’s response – Act not open to challenge – Inadmissibility.#Case T-637/25.

    judgment · EN · 12 October 2026

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

  • · GCEU · General Court

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.